Carcinoma, Pancreatic Ductal Clinical Trials in Lille
2 recruitingLille, France
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
Adenocarcinoma, Pancreatic Ductal
Genentech, Inc.260 enrolled89 locationsNCT05968326
Recruiting
Not Applicable
Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
PrognosisCarcinoma, Pancreatic Ductal
Institut Curie85 enrolled7 locationsNCT05475366